论文部分内容阅读
目的观察痰热清注射液治疗肾综合征出血热(HFRS)早期患者的临床疗效。方法将100例发病5d以内单纯发热期的HFRS患者随机分为治疗组与对照组各50例。对照组给予以林格液为主的综合治疗,治疗组同时加用痰热清注射液20ml,静脉滴注,每日1次,疗程5d。结果在病毒血症的改善、减轻病情、越期、肾功能和肝功能恢复、血小板复常、减少并发症、治疗率和总有效率诸方面,治疗组均显著优于对照组(P<0.05~0.01)。结论痰热清注射液治疗HFRS早期(≤5d)患者,有良好效果。
Objective To observe the clinical efficacy of Tanreqing Injection in the early treatment of patients with hemorrhagic fever with renal syndrome (HFRS). Methods 100 patients with HFRS within 5 days after onset of fever were randomly divided into treatment group and control group, 50 cases each. The control group was given Ringer’s solution-based comprehensive treatment. The treatment group also added Tanreqing injection 20ml intravenously once daily for 5 days. Results The treatment group was significantly better than the control group in the improvement of viremia, alleviation of disease, overdue, recovery of renal function and liver function, platelet remission, complications reduction, treatment rate and total effective rate (P <0.05 ~ 0.01). Conclusion Tanreqing injection in the treatment of HFRS early (≤ 5d) patients with good results.